STAAR Surgical Company (STAA): Price and Financial Metrics

STAAR Surgical Company (STAA): $59.86

-1.18 (-1.93%)

POWR Rating

Component Grades














  • Growth is the dimension where STAA ranks best; there it ranks ahead of 90.13% of US stocks.
  • STAA's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • STAA's current lowest rank is in the Momentum metric (where it is better than 7.15% of US stocks).

STAA Stock Summary

  • With a price/earnings ratio of 84.5, STAAR SURGICAL CO P/E ratio is greater than that of about 94.27% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for STAAR SURGICAL CO is higher than 95.02% of stocks in our set with a positive cash flow.
  • STAA's price/sales ratio is 11.44; that's higher than the P/S ratio of 90.26% of US stocks.
  • If you're looking for stocks that are quantitatively similar to STAAR SURGICAL CO, a group of peers worth examining would be OMCL, RGEN, OSS, TECH, and SPSC.
  • STAA's SEC filings can be seen here. And to visit STAAR SURGICAL CO's official web site, go to

STAA Valuation Summary

  • In comparison to the median Healthcare stock, STAA's EV/EBIT ratio is 973.68% higher, now standing at 81.6.
  • STAA's price/sales ratio has moved up 12 over the prior 243 months.

Below are key valuation metrics over time for STAA.

Stock Date P/S P/B P/E EV/EBIT
STAA 2022-11-01 13.5 11.8 105.5 81.6
STAA 2022-10-31 13.0 11.4 101.4 78.2
STAA 2022-10-28 13.1 11.4 101.8 78.6
STAA 2022-10-27 12.8 11.2 100.0 77.1
STAA 2022-10-26 13.3 11.6 103.5 79.9
STAA 2022-10-25 13.1 11.5 102.4 79.0

STAA Growth Metrics

    Its 3 year net cashflow from operations growth rate is now at 197.1%.
  • The year over year revenue growth rate now stands at 35.69%.
  • Its 4 year net income to common stockholders growth rate is now at 203.45%.
Over the past 15 months, STAA's revenue has gone up $82,629,000.

The table below shows STAA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 261.654 39.45 33.582
2022-03-31 242.92 32.586 29.111
2021-12-31 230.472 43.962 24.501
2021-09-30 217.469 55.014 22.906
2021-06-30 206.198 42.287 20.778
2021-03-31 179.025 35.888 11.039

STAA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • STAA has a Quality Grade of B, ranking ahead of 92.6% of graded US stocks.
  • STAA's asset turnover comes in at 0.762 -- ranking 41st of 186 Medical Equipment stocks.
  • NVNO, ADMT, and BLFS are the stocks whose asset turnover ratios are most correlated with STAA.

The table below shows STAA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-01 0.762 0.772 0.342
2021-07-02 0.784 0.764 0.341
2021-04-02 0.734 0.741 0.208
2021-01-01 0.713 0.724 0.110
2020-10-02 0.722 0.722 0.087
2020-07-03 0.720 0.722 0.056

STAA Price Target

For more insight on analysts targets of STAA, see our STAA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $147.00 Average Broker Recommendation 1.5 (Moderate Buy)

STAA Stock Price Chart Interactive Chart >

Price chart for STAA

STAA Price/Volume Stats

Current price $59.86 52-week high $112.27
Prev. close $61.04 52-week low $49.03
Day low $59.67 Volume 154,800
Day high $61.60 Avg. volume 477,378
50-day MA $69.26 Dividend yield N/A
200-day MA $73.31 Market Cap 2.89B

STAAR Surgical Company (STAA) Company Bio

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.

STAA Latest News Stream

Event/Time News Detail
Loading, please wait...

STAA Latest Social Stream

Loading social stream, please wait...

View Full STAA Social Stream

Latest STAA News From Around the Web

Below are the latest news stories about STAAR SURGICAL CO that investors may wish to consider to help them evaluate STAA as an investment opportunity.

STAAR Surgical Opens EVO Experience Center in United States

LAKE FOREST, Calif., November 17, 2022--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the opening of the first company-operated EVO Experience Center. The center is located at STAAR’s corporate headquarters in Lake Forest, California within close proximity to Orange County’s John Wayne Airport (SNA).

Yahoo | November 17, 2022

Is Now An Opportune Moment To Examine STAAR Surgical Company (NASDAQ:STAA)?

STAAR Surgical Company ( NASDAQ:STAA ), might not be a large cap stock, but it saw a double-digit share price rise of...

Yahoo | November 13, 2022

Are Options Traders Betting on a Big Move in STAAR (STAA) Stock?

Investors need to pay close attention to STAAR (STAA) stock based on the movements in the options market lately.

Yahoo | November 11, 2022

Staar Surgical (STAA) Q3 Earnings and Revenues Beat Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of 76.19% and 1.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 2, 2022

STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y

LAKE FOREST, Calif., November 02, 2022--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 30, 2022.

Yahoo | November 2, 2022

Read More 'STAA' Stories Here

STAA Price Returns

1-mo -15.89%
3-mo -37.37%
6-mo -9.22%
1-year -38.40%
3-year 62.27%
5-year 258.44%
YTD -34.44%
2021 15.25%
2020 125.25%
2019 10.22%
2018 105.87%
2017 42.86%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7253 seconds.